AVI BioPharma News http://www.avibio.com/ AVI BioPharma News and Press Releases Fri, 26 Jun 2009 09:00:00 PDT AVI BioPharma Joining Russell 3000 Index http://www.avibio.com/pr/pr423.php PORTLAND, OR — June 26, 2009 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that immediately following the close of the U.S. markets today it will join the broad-market Russell 3000® Index following Russell Investments’ annual reconstitution of its comprehensive set of U.S. and global equity indexes. [more...] Fri, 26 Jun 2009 09:00:00 PDT http://www.avibio.com/pr/pr423.php AVI BioPharma Under Contract with U.S. Defense Threat Reduction Agency for Development of Therapeutics Targeting H1N1 Swine Flu http://www.avibio.com/pr/pr422.php PORTLAND, OR — June 21, 2009 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, is under contract with the U.S. Defense Threat Reduction Agency (DTRA) for development of one or more nucleotide-based candidate drugs targeting the present epidemic of H1N1 swine flu. [more...] Sun, 21 Jun 2009 23:08:00 PDT http://www.avibio.com/pr/pr422.php AVI BioPharma, Inc. to Present at 7th Annual Biodefense Vaccines & Therapeutics Conference in Washington D.C. http://www.avibio.com/pr/pr421.php PORTLAND, OR — June 10, 2009 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Patrick Iversen, Ph.D., Senior Vice President of Strategic Alliances, will present at the upcoming 7th Annual Biodefense Vaccines & Therapeutics conference taking place in Washington D.C. [more...] Wed, 10 Jun 2009 05:00:00 PDT http://www.avibio.com/pr/pr421.php